LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-2-oxo-tetrahydrofuranyl)-carbothioic acid ester,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-acyl-17&agr;-propynyl-11&bgr;-(cyclic amino) aryl...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-acyl-17&agr;-propynyl-11&bgr;-arylsteroids and their...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-amino and hydroxylamino-11&bgr;-arylsteroids and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-amino and hydroxylamino-11&bgr;-arylsteroids and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

17&bgr;-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

17,20(E)-dehydro vitamin D analogs and their uses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

17,20(E)-dehydro vitamin D analogs and their uses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

17,20(Z)-dehydro vitamin D analogs and their uses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

17-β hydroxysteroid dehydrogenase type 3 inhibitors...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-(3-furyl)-5.beta., 14.beta.-androstane derivatives active on

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-(4-pyridazinyl) -5.beta., 14.beta.-androstane derivatives act

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

17-(cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-.alpha.-acyl steroids which inhibit 5-.alpha.-reductase

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-.alpha.and 17-.beta.substituted acyl-3-carboxy-3,5-dienes and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

17-alkyl-7-substituted-4-aza steroid derivatives as 5-.alpha.-re

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

17-amino substituted 4-azasteroid 5.alpha.-reductase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-aryl and 17-heterocyclyl-14.beta.-5.alpha.-androstane, andros

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-Aryl and 17-heterocyclyl-5.beta.,14.beta.-androstane derivati